Detalles de la búsqueda
1.
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Cancer Immunol Immunother
; 73(6): 106, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38634928
2.
The interaction between early life complications and a polygenic risk score for schizophrenia is associated with brain activity during emotion processing in healthy participants.
Psychol Med
; : 1-10, 2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38305128
3.
Microbiota and prostate cancer.
Semin Cancer Biol
; 86(Pt 3): 1058-1065, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34536504
4.
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial.
Lancet
; 400(10358): 1103-1116, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36099926
5.
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study.
Cancer Immunol Immunother
; 72(6): 1381-1394, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695827
6.
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis.
Cancer Immunol Immunother
; 72(6): 1365-1379, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36633661
7.
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Cancer Immunol Immunother
; 72(9): 2961-2970, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37248424
8.
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Cancer Immunol Immunother
; 72(11): 3665-3682, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676282
9.
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type.
Histopathology
; 83(3): 465-476, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37317674
10.
The role of bioelectrical phase angle in patients with heart failure.
Rev Endocr Metab Disord
; 24(3): 465-477, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36282462
11.
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer.
Int J Mol Sci
; 24(10)2023 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37240284
12.
Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data.
Anticancer Drugs
; 33(1): e61-e68, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387596
13.
A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents.
Anticancer Drugs
; 33(1): e43-e51, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387593
14.
Risk of toxicity with immunotherapy-tyrosine kinase inhibitors for metastatic renal cell carcinoma: a meta-analysis of randomized controlled trials.
Future Oncol
; 18(5): 625-634, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34927453
15.
Impact of clinicopathological features on immune-based combinations for advanced urothelial carcinoma: a meta-analysis.
Future Oncol
; 18(6): 739-748, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35048736
16.
Respiratory failure and bioelectrical phase angle are independent predictors for long-term survival in acute heart failure.
Scand Cardiovasc J
; 56(1): 28-34, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35389300
17.
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.
Oncologist
; 26(9): 740-750, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34077597
18.
Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16).
Oncology
; 99(12): 747-755, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34583356
19.
Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center study.
Anticancer Drugs
; 32(1): 74-81, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33290315
20.
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.
BJU Int
; 128(2): 254-261, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33547860